-
Je něco špatně v tomto záznamu ?
Negative prognostic significance of primary cilia, CD8+ tumor infiltrating lymphocytes and PD1+ cells expression in clear cell renal cancer
A. Rozsypalova, B. Rosova, A. Filipova, DH. Nikolov, R. Chloupkova, I. Richter, J. Proks, R. Zachoval, R. Matej, B. Melichar, T. Buchler, J. Dvorak,
Jazyk angličtina Země Řecko
Typ dokumentu časopisecké články
PubMed
31646820
Knihovny.cz E-zdroje
- MeSH
- antigeny CD279 genetika MeSH
- CD8-pozitivní T-lymfocyty patologie MeSH
- cilie genetika patologie MeSH
- dospělí MeSH
- Kaplanův-Meierův odhad MeSH
- karcinom z renálních buněk genetika patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- přežití bez známek nemoci MeSH
- prognóza * MeSH
- regulace genové exprese u nádorů MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- tumor infiltrující lymfocyty patologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: The aim of this study was to investigate the potential association and combined prognostic significance of the frequency of primary cilia (PC), programmed cell death protein-1 receptor (PD1) and CD8+ tumor infiltrating lymphocytes (TIL) in patients with clear cell renal cancer (ccRCC). METHODS: The frequency of PC, PD1 expression and the frequency of intratumoral CD8+ TIL were evaluated in 104 ccRCC patients. RESULTS: The median frequency of PC was 0.003. The expression of PD1+ cells were <5% in 52 patients, 5-25% in 34 patients and 26-50% in 13 patients and >50% in 5 patients. Intratumoral CD8+ TIL were evaluable in all patients: negative in 1 patient, <25% in 63, 26-50% in 29 and >50% in 11 patients. Overall survival (OS) according to the frequency of PC was significantly shorter in patients with higher frequency (≥0.002) than in patients with lower frequency (<0.002) (p<0.001). Median OS was significantly shorter in patients with higher (25%) CD8+ TIL and higher (>25%) PD1+ expression than in patients with lower (<25%) expression (4.6 vs. 97. years, p=0.006 and 2.9 vs. 8.9 years, p=0.006, respectively). CONCLUSIONS: The present study provides the first data on the potential association and combined prognostic significance of frequency of PC, PD1+ cells and CD8+ TIL in patients with clear cell renal cancer.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005763
- 003
- CZ-PrNML
- 005
- 20200528105354.0
- 007
- ta
- 008
- 200511s2019 gr f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)31646820
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Rozsypalova, Aneta $u 1Department of Oncology, First Medical Faculty, Charles University and Thomayer Hospital, Prague, Czech Republic.
- 245 10
- $a Negative prognostic significance of primary cilia, CD8+ tumor infiltrating lymphocytes and PD1+ cells expression in clear cell renal cancer / $c A. Rozsypalova, B. Rosova, A. Filipova, DH. Nikolov, R. Chloupkova, I. Richter, J. Proks, R. Zachoval, R. Matej, B. Melichar, T. Buchler, J. Dvorak,
- 520 9_
- $a PURPOSE: The aim of this study was to investigate the potential association and combined prognostic significance of the frequency of primary cilia (PC), programmed cell death protein-1 receptor (PD1) and CD8+ tumor infiltrating lymphocytes (TIL) in patients with clear cell renal cancer (ccRCC). METHODS: The frequency of PC, PD1 expression and the frequency of intratumoral CD8+ TIL were evaluated in 104 ccRCC patients. RESULTS: The median frequency of PC was 0.003. The expression of PD1+ cells were <5% in 52 patients, 5-25% in 34 patients and 26-50% in 13 patients and >50% in 5 patients. Intratumoral CD8+ TIL were evaluable in all patients: negative in 1 patient, <25% in 63, 26-50% in 29 and >50% in 11 patients. Overall survival (OS) according to the frequency of PC was significantly shorter in patients with higher frequency (≥0.002) than in patients with lower frequency (<0.002) (p<0.001). Median OS was significantly shorter in patients with higher (25%) CD8+ TIL and higher (>25%) PD1+ expression than in patients with lower (<25%) expression (4.6 vs. 97. years, p=0.006 and 2.9 vs. 8.9 years, p=0.006, respectively). CONCLUSIONS: The present study provides the first data on the potential association and combined prognostic significance of frequency of PC, PD1+ cells and CD8+ TIL in patients with clear cell renal cancer.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a CD8-pozitivní T-lymfocyty $x patologie $7 D018414
- 650 _2
- $a karcinom z renálních buněk $x genetika $x patologie $7 D002292
- 650 _2
- $a cilie $x genetika $x patologie $7 D002923
- 650 _2
- $a přežití bez známek nemoci $7 D018572
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a tumor infiltrující lymfocyty $x patologie $7 D016246
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a prognóza $7 D011379
- 650 _2
- $a antigeny CD279 $x genetika $7 D061026
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rosova, Blanka
- 700 1_
- $a Filipova, Alzbeta
- 700 1_
- $a Nikolov, Dimitar Hadzi
- 700 1_
- $a Chloupkova, Renata
- 700 1_
- $a Richter, Igor
- 700 1_
- $a Proks, Jan
- 700 1_
- $a Zachoval, Roman
- 700 1_
- $a Matej, Radoslav
- 700 1_
- $a Melichar, Bohuslav
- 700 1_
- $a Buchler, Tomas
- 700 1_
- $a Dvorak, Josef
- 773 0_
- $w MED00005361 $t Journal of B.U.ON. : official journal of the Balkan Union of Oncology $x 2241-6293 $g Roč. 24, č. 4 (2019), s. 1644-1651
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31646820 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200528105352 $b ABA008
- 999 __
- $a ok $b bmc $g 1524621 $s 1095819
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 24 $c 4 $d 1644-1651 $e - $i 2241-6293 $m Journal of Balkan Union of Oncology $n J BUON $x MED00005361
- LZP __
- $a Pubmed-20200511